...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF LEVOSULPIRIDE AND RABEPRAZOLE SODIUM: A NEW ANALYTICAL Q-ABSORBANCE RATIO APPROACH
【24h】

METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF LEVOSULPIRIDE AND RABEPRAZOLE SODIUM: A NEW ANALYTICAL Q-ABSORBANCE RATIO APPROACH

机译:左旋硫醚和雷贝拉唑钠同时估算的方法开发和验证:一种新的Q-吸光度比法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: The aim of the study was to develop a precise, accurate, and rapid ultraviolet spectrophotometric method for simultaneous estimation of levosulpiride (LEVO) and rabeprazole sodium (RBS) in the binary mixture and to validate the method as per ICH guidelines. Method: Estimation of LEVO and RBS was performed by Q-absorbance method. Analysis was performed using the ratio of absorbance at two selected wavelengths, one at iso-absorptive point and other is the absorbance maxima of any one of the components. Single scan spectrum and the overlain spectrum conclude that absorbance maxima of LEVO and RBS are 228 and 291.8 nm, respectively, with a coinciding iso-absorptive point at 255 nm. Method uses a ratio of absorbance for assay at 255 and the second wavelength is 291.8 nm, λmax for RBS. It is also applicable at 228 nm, as the second wavelength. Results: Linearity of LEVO and RBS was found to be 25-125 and 4-36 μg/ml, respectively. The accuracy of the LEVO and RBS was found 99.26% and 99.51%, respectively and Sandell’s sensitivity ranged between 0.0238 and 0.594 μg/cm2. Assay of LEVO (75 mg) and RBS (20 mg) in capsule dosage form was found 99.5% and 98.69% w/w, respectively. Conclusions: The developed method for the estimation of LEVO and RBS in binary mixture were found to be simple, accurate, robust, and reproducible. No interference of excipients and the degraded product was found during the estimation. Therefore, the method can be successfully applied for routine quality control analysis. RBS) in the binary mixture and to validate the method as per ICH guidelines. Method: Estimation of LEVO and RBS was performed by Q-absorbance method. Analysis was performed using the ratio of absorbance at two selected wavelengths, one at iso-absorptive point and other is the absorbance maxima of any one of the components. Single scan spectrum and the overlain spectrum conclude that absorbance maxima of LEVO and RBS are 228 and 291.8 nm respectively with a coinciding iso-absorptive point at 255 nm. Method uses ratio of absorbance for assay at 255 and the second wavelength is 291.8 nm, λ max for RBS. It is also applicable at 228 nm, as the second wavelength. Results: Linearity of LEVO and RBS were found to be 25-125and 4-36 μg/ml respectively. Accuracy of the LEVO and RBS was found 99.26 and 99.51% respectively and Sandell’s sensitivity ranged between 0.0238 and 0.594 ??g/cm 2 . Assay of LEVO (75 mg) and RBS (20 mg) in capsule dosage form was found 99.5 and 98.69% w/w respectively. Conclusions: The developed method for the estimation of LEVO and RBS in binary mixture were found to be simple, accurate, robust and reproducible. No interference of excipients and the degraded product were found during the estimation. Therefore the method can be successfully applied for routine quality control analysis.
机译:目的:本研究的目的是开发一种精确,准确和快速的紫外分光光度法,该方法可同时估算二元混合物中的左旋磺酰脲(LEVO)和雷贝拉唑钠(RBS),并根据ICH指南对该方法进行验证。方法:采用Q吸收法估算LEVO和RBS。使用在两个选定波长处的吸光度比率进行分析,一个在等吸收点,另一个是任何一种组分的最大吸光度。单次扫描光谱和重叠光谱的结论是,LEVO和RBS的最大吸光度分别为228和291.8 nm,等吸收点在255 nm处重合。该方法使用吸光度比值在255处测定,第二个波长为291.8 nm,RBS为λmax。它也可以在228 nm处用作第二波长。结果:LEVO和RBS的线性分别为25-125和4-36μg/ ml。 LEVO和RBS的准确度分别为99.26%和99.51%,Sandell的灵敏度介于0.0238和0.594μg/ cm2之间。胶囊剂型的LEVO(75 mg)和RBS(20 mg)含量分别为99.5%和98.69%w / w。结论:开发的估算二元混合物中LEVO和RBS的方法简单,准确,稳健且可重现。在估算过程中未发现赋形剂和降解产物的干扰。因此,该方法可以成功地应用于常规质量控制分析。 RBS)并按照ICH指南验证方法。方法:采用Q吸收法估算LEVO和RBS。使用在两个选定波长处的吸光度比率进行分析,一个在等吸收点,另一个是任何一种组分的最大吸光度。单次扫描光谱和重叠光谱的结论是,LEVO和RBS的最大吸光度分别为228和291.8 nm,等吸收点在255 nm处重合。该方法使用吸光度比值在255处进行测定,第二波长为291.8 nm,RBS为λmax。它也可以在228 nm处用作第二波长。结果:LEVO和RBS的线性分别为25-125和4-36μg/ ml。 LEVO和RBS的准确度分别为99.26%和99.51%,Sandell的灵敏度范围为0.0238至0.594?g / cm 2。胶囊剂型的LEVO(75 mg)和RBS(20 mg)含量分别为99.5%和98.69%w / w。结论:开发的估算二元混合物中LEVO和RBS的方法简单,准确,稳健且可重现。在估计过程中未发现赋形剂和降解产物的干扰。因此,该方法可以成功地应用于常规质量控制分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号